Lead Sponsor

Apnimed

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

•1. ≥18 years of age at the time of informed consent.
•2. PSG criteria: AHI of ≥10 and ≤45; ≤ 25% central or mixed apneas; and PLM arousal index ≤15
•3. PROMIS-Fatigue: raw score ≥17
•4. PAP intolerance or current PAP refusal.
•5. BMI between 18.5 and 40 kg/m2 for men, or 42 kg/m2 for women, inclusive.

•1. Narcolepsy, restless leg syndrome, REM sleep behavior disorder
•2. Insomnia disorder characterized by difficulty initiating or maintaining sleep, or use within the past month of sedative-hypnotics or other medication for the purpose of treating or avoiding insomnia symptoms.
•3. Pierre Robin, Treacher Collins, or other craniofacial malformation syndrome, or grade ≥3 tonsillar hypertrophy.
•4. Clinically significant cardiac disease, e.g., ventricular arrhythmia, untreated or unstable coronary artery disease, cardiac failure. Stable atrial arrhythmia is allowed.
•5. Neuromuscular disorder (e.g., motor neuron disease, muscular dystrophy or myopathy, myasthenic syndrome); epilepsy; Parkinson, Alzheimer, or other neurodegenerative disease.
•\-

Related studies

NCT06498648 · Advanced Dedifferentiated Liposarcoma, Advanced Leiomyosarcoma, and more

NCT07575867 · Atrial Fibrillation, Stroke Prevention in Patients With Atrial Fibrillation, and more

NCT05872204 · Low Grade Serous Ovarian Carcinoma, Adult Type Granulosa Cell Tumor

NCT04333537 · Buccal Mucosa Squamous Cell Carcinoma, Floor of Mouth Squamous Cell Carcinoma, and more

NCT03429036 · Hearing Disorder, Oral Mucosal Disease, and more

Parallel-Arm Study to Compare AD109 to Placebo With Patients With OSA (SynAIRgy Study)